News / Blog
Delivery and Holidays in September
Catalog
Edaravone Generic (Radicava, Radicut) - 20 ml x 10 ampoules (30 mg)
Product Code :
Availability : 17
USD 490.00
General information on Edaravon generic from Japan.
Official manufacturer: Nichi-iko Pharmaceutical Co., Ltd., Japan
Active component: edaravone.
Start of sales: in Japan after clinical trials (conducted throughout the country in 137 cases) in 2001, June.
Medical effect: protection of brain cells. Used for ALS, stroke symptoms, cerebral theray etc.
Package details: 20 ml x 10 ampoules (30 mg).
Precautions and contraindications: please check full list here.
Radicut's main purpose is to protect the brain cells of patients that suffer cerebrovascular blood flow. The drug has shown itself very effective in clinical trials in Japan and the United States. The drug is also known as Edaravone. Since permission for the use of the release of the drug in Japan, Radicut has been tested in a variety of hospitals and has shown very good results. The main function of the drug is to protect the brain cells of patients with ischemic blood flow. Since the permission to use in Japan Radicut has been assigned to over 180,000 patients.
Edaravone Radicut (Radicava) - Treatment or simple Support?
For a long time, the diagnosis of ALS (amyotrophic lateral sclerosis) was same as lethal sentence. There was no effective treatment for ALS, and there were no even ways to significantly slow down the process of patient’s passing out. This terrible disease was a real nightmare for patients for many years.
Innovative method of applying Edaravone Radicut
However, the situation changed when a unique Radical Edaravone preparation was developed in Japan. This drug is known by many names (Radicut, Edaravon, Radikava, Radicat, Edaravone, Radicawa), however the active substance and the principle of its medical effect remain the same. Radicut Edaravone from Japan normalizes the blood circulation of the brain and suppresses the symptoms of ALS with the help of innovative chemical compounds developed in Japan for the treatment of ALS. The drug protects the brain cells, dramatically inhibiting the processes of atrophy or reducing them completely and, thereby, prolonging the life of patients.
Proven effects of Edaravone Radicut
Due to the proven clinical effect of Radicut Edaravone Radicava in Japan, more than 200,000 patients have received this treatment. Certainly, there are certain risks of using this drug, as well as any other strong and effective medicine for a serious disease. However, the effect of using Edaravone Radicut surpasses all associated risks in most cases. This drug has been clinically tested and registered in the United States under the Radicava brand name - and for the first time in the world has been approved by the FDA (known for its severe drug efficacy requirements) to sell the drug to the domestic market in America. It was possible to get Edaravone radicut until recent time only in the USA and Japan, and it was available only to a small circle of people due to the high price, but now price was lowered.
How to apply Edaravone Radicut (Radicava)
Everything changed several years ago, when the manufacturer lowered the price and published methods of using the drug not only to treat ALS, but also to improve the consequences of ischemic stroke. Depending on your symptom, one of two methods of treatment with Radicut Edaravone from Japan is recommended. The cycle requires either one or two ampoules a day for 2 weeks, the cycle is repeated with a certain intensity to achieve a stable effect of treatment. Due to the strong effect of the drug, it is recommended to undergo treatment only under the supervision of a specialized doctor.
How to get genuine Edaravone Radicut from Japan?
You can order Radikat Edaravone today online. For clients residing in other countries, we will inform all necessary documents and procedures for obtaining the medicine. The set of documents is extremely small. There are possible minimum import duties, but we will do our part to minimize them as much as possible to save your money.
Import of goods for personal use (not licensed in the country of residence) is allowed EVERYWHERE and ALWAYS - the customs shall give you medicines you ordered for personal use if you have diagnosis paper or prescription. Consult a specialist in our Japanese Health Store about how to get Radicut Edaravone from Japan. We will provide you with full support and prompt you how to order Radicut Edaravone directly from Japan without intermediaries at a sale price.
Edaravone Radicut from Japan - pro et contra
DOSAGE AND ADMINISTRATION of Edaravone Radicava
1. Edaravone Improves of neurological symptoms, disorder of activities of daily living, and functional disorder associated with acute ischaemic stroke The usual adult dosage is one ampoule (30 mg of edaravone) diluted with an appropriate volume of physiological saline, etc., which is administered intravenously over 30 minutes twice a day in the morning and the evening. Administration of this product should be initiated within 24 hours after the onset of the disease, and the duration of administration should be within 14 days.
2. Edaravone Inhibites on progression of functional disorder in patients with amyotrophic lateral sclerosis (ALS) The usual adult dosage is two ampoules (60 mg of edaravone) diluted with an appropriate volume of physiological saline, etc., which is administered intravenously over 60 minutes once a day. Usually, the duration of administration and cessation of this product are combined in one cycle of treatment for 28 days and the cycle should be repeated. This product is consecutively infused for 14 days in the duration of administration followed by cessation for 14 days in the 1st cycle, and from the 2nd cycle, this product is infused for 10 of 14 days in the duration of administration followed by cessation for 14 days.
Clinical studies of Edaravone: related researches.
The efficacy of Radicat for the treatment of amyotrophic lateral sclerosis ALS was scientifically proven during a randomized clinical trial in Japan for 137 patients, which took place for over six months.
In the first row of studies of Radicut, only patients with ALS who are already in phase Three failed to record major improvements on the ALSFRS-R scale (Amyotroph Lateral Scler Frontotemporal Degener, 2014; 15; 610–7). Therefore, a repeated study was conducted involving 181 patients. During this study, the findings confirmed, that it is imperative to start therapy in a timely manner and conduct full courses of treatment.
Radicut mediocne (also known as Radikawa Edaravon) was officially approved by the US government (the drug monitoring organization FDA - link to the site here). Radicut conducted a mass of basic research. Doctors Otomo and Hawkin in their works Otomo, E. et al .: Cerebrovasc. Dis. 2003 ; 15 : 222-229, Houkin, K. et al .: J. Stroke Cerebrovasc. Dis. 1998 ; 7 (5) : 315-322 showed the main effects from the use of the drug, outlined areas of risk and provided a picture of the dynamics of the patients. Doctor of Medicine Abe Abe, K. et al .: Amyotroph Lateral Scler Frontotemporal Degener. 2014 ; 15 (7-8) : 610-617 in his work drew attention to the interaction of this drug with other medicines and its overall effect on the patient's body. His own studies are exploring the possibilities and methods of treating the effects of strokes - Abe, K. et al. : Stroke 1988 ; 19 (4):480-485.
In general, at the time of release of this medicine in Japan, there were more than fifty fundamental works and studies on this drug, mainly in Japanese. Much of the research has been done by Dr. Komatsu Teiko (小松貞子他: 薬物動態 1996 ; 11 (5) : 463-480) and deals with the degree of effectiveness and side effects of this drug, as well as methods to minimize them.
Articles about Edaravone
You may be interested to check the following related articles in our blog section:
Japanese medicines for the treatment of ALS
Radicut Edaravone: Contraindications and Precautions
Radiсut Edaravone - treatment or support?
Clinical studies of Radicut